Published • loading... • Updated
First-in-human trial now testing oral FA drug in healthy volunteers
Summary by Friedreich's Ataxia News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
First-in-human trial now testing oral FA drug in healthy volunteers
A first-in-human trial testing Adjuvia Therapeutics‘ ATI-105 for Friedreich’s ataxia (FA) — an oral therapy derived from bacteria and engineered to cross a barrier protecting the brain — is now underway, having dosed its first participant. The Phase 1 study (NCT07869654), sponsored by the California-based biotech, is testing the safety and pharmacological properties of ATI-105 […] The post First-in-human trial now testing oral FA drug in healthy…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
